WOLF MYLES received a stock award from AKEBIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/11/2025ACC: 0001562180-25-004722
+89.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
89.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35.70K
Price / share
—
Trade value
—
% of position
36.5%
6/10/2025
97.68K→133.38K
Total
Net shares
+35.70K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2025 | A · Award | +35.70K | — | — | 36.5% | 97.68K | 133.38K |
| Total | +35.70K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
53.60K shares
Shares
+53.60K
Strike price
3.92
Held after
53.60K
Exercisable
—
6/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock53.60K shares | 6/10/2025 | A · Award | +53.60K | 3.92 | — | 53.60K |